2017, organized by the European Society for Medical Oncology, will be held at IFEMA from 8th to 12th of September. This indispensable meeting point for oncology professionals will gather in Madrid more than 20,000 doctors, scientists and researchers from all over the world.
The latest in cancer treatments, one of the most relevant medical issues today, will be presented during this essential event for the European and global medical community. At a medical level, an especially important challenge in this edition is to break down some barriers and integrate molecular biology into the clinical scene. But beyond being a congress full of knowledge, it is a congress that also seeks to recognize the research work of great professionals on prevention and diagnosis in the treatment and palliative care of cancer, putting into practice the most innovative forms of scientific communication.
ESMO returns to IFEMA after its very successful 2014 edition, which brought together 20,000 delegates – more than 80% of them foreigners – generating revenues of more than 20 million euros and 75,000 overnight stays.
In fact, the attractiveness of IFEMA and Madrid was seen in the fact that the congress then achieved a growth of 23% of attendance compared to the previous edition in Vienna.
The event was an important economic injection for Madrid, a city very well prepared to host major world events as is shown this year in which congresses of large societies (respiratory diseases, nephrology, air transport, palliative care, among others) take place in IFEMA. Besides its good connections, hotel infrastructure, variety of leisure, gastronomic and cultural offerings, and climate, Madrid boasts what is key in the decisions of these large societies: a first-class conference center such as IFEMA.
ESMO 2014 GENERATED MORE THAN 20 MILLION EUROS AND 75,000 OVERNIGHT STAYS FOR THE CITY